ILC Dover’s soloPure flexible aseptic isolator creates a closed environment for sterile filling.
ILC Dover
ILC Dover’s soloPure flexible, single-use aseptic isolator is a cost-effective, closed-barrier system for sterile pharmaceutical drug product manufacturing. The isolator creates a closed, Grade-A, aseptic environment for fill/finish activities requiring positive and negative pressures, and is an alternative to conventional barrier systems.
The disposable chamber allows rapid changeover. The efficient design has a small footprint, enhances operator access with double-sided entry, and mitigates risk with integrity testing throughout its lifecycle. The system is beneficial for handling sterile potent powders and other challenging products that require containment and has options to sterilize in-place with vaporized hydrogen peroxide or operate with a single-use, disposable, gamma-irradiated chamber.
Source: ILC Dover
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.